Commercial Pharmaceutical Supply – Doxycycline Hyclate Tablets

The contract entails the supply of 2,000 bottles of Doxycycline Hyclate Tablets, each containing 100 mg of the active ingredient, to meet precise U.S. military pharmaceutical standards. The product must comply with both the National Stock Number and National Drug Code specifications mandated by the Department of Defense to ensure interoperability and traceability within military medical systems. Packaging and labeling requirements are strictly aligned with U.S. military guidelines, covering everything from container type and sterility to barcode formatting and labeling content to support logistics and administration aboard naval vessels. Delivery is intended for a Navy vessel, underscoring the operational criticality of timely and accurate pharmaceutical provisioning in deployed environments. The contract, classified as a subcontract under NAICS code 325412, falls under the purview of the Defense Logistics Agency and was posted on July 17, 2026. The specific award details are accessible via the DIBBS portal using the provided contract and delivery identifiers, reflecting formalized procedures for acquisition and accountability within Defense Department medical supply chains. There is no set-aside designation, indicating the opportunity is open to all qualified commercial suppliers meeting the technical and regulatory criteria.